Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TP53 R175H
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
NTRK1-TP53 fusion (1)
NTRK1-TP53 fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 R175H
Ovarian Cancer
TP53 R175H
Ovarian Cancer
carboplatin + paclitaxel
Resistant: C3 – Early Trials
carboplatin + paclitaxel
Resistant
:
C3
carboplatin + paclitaxel
Resistant: C3 – Early Trials
carboplatin + paclitaxel
Resistant
:
C3
TP53 R175H
Colorectal Cancer
TP53 R175H
Colorectal Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
TP53 R175H
Breast Cancer
TP53 R175H
Breast Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
TP53 R175H
Gastric Cancer
TP53 R175H
Gastric Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
TP53 R175H
Non Small Cell Lung Cancer
TP53 R175H
Non Small Cell Lung Cancer
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
TP53 R175H
Solid Tumor
TP53 R175H
Solid Tumor
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
TP53 R175H
Non Small Cell Lung Cancer
TP53 R175H
Non Small Cell Lung Cancer
crizotinib
Sensitive: C4 – Case Studies
crizotinib
Sensitive
:
C4
crizotinib
Sensitive: C4 – Case Studies
crizotinib
Sensitive
:
C4
TP53 R175H
Prostate Cancer
TP53 R175H
Prostate Cancer
APR-548
Sensitive: D – Preclinical
APR-548
Sensitive
:
D
APR-548
Sensitive: D – Preclinical
APR-548
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.